| Followers | 73 |
| Posts | 3426 |
| Boards Moderated | 1 |
| Alias Born | 04/28/2004 |
Wednesday, June 23, 2004 9:24:51 PM
Re: Ariad and similar, early stage cancer compounds...
This is a late reply. However as a matter of strategy, I often will start small positions in companies that have scientifically interesting compounds in phase I. I've done so with Ariad, as well as ARQL. I find that the biotechs developing such compounds are often cheap, and since it is practically impossible to know how a drug will do in phase I... it's worth the small gamble.
But they have to be "scientifically" interesting. Don't ask me exactly what that means
This is a late reply. However as a matter of strategy, I often will start small positions in companies that have scientifically interesting compounds in phase I. I've done so with Ariad, as well as ARQL. I find that the biotechs developing such compounds are often cheap, and since it is practically impossible to know how a drug will do in phase I... it's worth the small gamble.
But they have to be "scientifically" interesting. Don't ask me exactly what that means
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
